Format

Send to

Choose Destination
Curr Opin Pediatr. 2018 Feb;30(1):57-64. doi: 10.1097/MOP.0000000000000567.

Management of hypertonia in cerebral palsy.

Author information

1
Department of Orthopaedic Surgery, Henry Ford Hospital, Detroit, Michigan, USA.
2
Department of Orthopaedics, The Royal Children's Hospital, Parkville, Victoria, Australia.
3
Department of Physical Medicine and Rehabilitation.
4
Department of Orthopaedic Surgery, Gillette Children's Specialty Healthcare, St. Paul, Minnesota, USA.

Abstract

PURPOSE OF REVIEW:

The review provides an update on the treatment of hypertonia in cerebral palsy, including physical management, pharmacotherapy, neurosurgical, and orthopedic procedures.

RECENT FINDINGS:

Serial casting potentiates the effect of Botulinum neurotoxin A injections for spasticity. Deep brain stimulation, intraventricular baclofen, and ventral and dorsal rhizotomy are emerging tools for the treatment of dystonia and/or mixed tone. The long-term results of selective dorsal rhizotomy and the timing of orthopedic surgery represent recent advances in the surgical management of hypertonia.

SUMMARY:

Management of hypertonia in cerebral palsy targets the functional goals of the patient and caregiver. Treatment options are conceptualized as surgical or nonsurgical, focal or generalized, and reversible or irreversible. The role of pharmacologic therapies is to improve function and mitigate adverse effects. Further investigation, including clinical trials, is required to determine the role of deep brain stimulation, intraventricular baclofen, orthopedic procedures for dystonia, and rhizotomy.

PMID:
29135566
DOI:
10.1097/MOP.0000000000000567
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center